Bone Biologics Corp

BBLGSEC EDGAR

Orthopedic, Prosthetic & Surgical Appliances & Supplies(DE)CIK: 1419554

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues	—	—	—	—	—
Research and Development Expense	$2.1M	$6.9M	$1.6M	$82.0K	$340.7K
Operating Expenses	$4.2M	$9.4M	$3.7M	$1.1M	$825.0K
Operating Income (Loss)	-$4.2M	-$9.4M	-$3.7M	-$1.1M	-$825.0K
Interest Expense	—	—	—	—	—
Nonoperating Income (Expense)	$106.7K	$479.6K	$2.2M	-$507.6K	-$998.1K
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	—	—	—	—

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$3.9M	$3.7M	$8.5M	$6.7M	$6.7M
Assets, Current	$3.9M	$3.7M	$8.5M	—	—
Cash and Cash Equivalents, at Carrying Value	—	—	—	—	$6.7M
Liabilities	$377.7K	$831.4K	$2.5M	$99.9K	$13.7M
Liabilities, Current	$377.7K	$831.4K	$2.5M	$99.9K	—
Accounts Payable, Current	—	—	—	—	—
Stockholders' Equity Attributable to Parent	$2.9M	$5.9M	$6.6M	-$13.7M	-$11.9M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$4.1M	-$9.6M	-$3.6M	-$1.2M	-$426.9K
Net Cash Provided by (Used in) Investing Activities	—	—	—	—	—
Net Cash Provided by (Used in) Financing Activities	$4.4M	$5.0M	$4.4M	$7.9M	$402.8K
Payments to Acquire Property, Plant, and Equipment	—	—	—	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)